Detection of SARS-CoV-2 B.1.1.529 (omicron) variant by SYBR green‑based RT‑qPCR

IF 2.5 Q3 BIOCHEMICAL RESEARCH METHODS
Fadi Abdel-Sater, R. Makki, Alia Khalil, Nader Hussein, Nada Borghol, Ziad Abi Khattar, Aline Hamade, Nathalie Khreich, Mahoumd El Homsi, Hussein Kanaan, Line Raad, Najwa Skafi, Fatima Al-Nemer, Zeinab Ghandour, Nabil El-zein, Mohamad Abou-Hamdan, H. Akl, E. Hamade, B. Badran, K. Hamze
{"title":"Detection of SARS-CoV-2 B.1.1.529 (omicron) variant by SYBR green‑based RT‑qPCR","authors":"Fadi Abdel-Sater, R. Makki, Alia Khalil, Nader Hussein, Nada Borghol, Ziad Abi Khattar, Aline Hamade, Nathalie Khreich, Mahoumd El Homsi, Hussein Kanaan, Line Raad, Najwa Skafi, Fatima Al-Nemer, Zeinab Ghandour, Nabil El-zein, Mohamad Abou-Hamdan, H. Akl, E. Hamade, B. Badran, K. Hamze","doi":"10.1093/biomethods/bpae020","DOIUrl":null,"url":null,"abstract":"\n The COVID-19 pandemic is unceasingly spreading across the globe, and recently a highly transmissible Omicron SARS-CoV-2 variant (B.1.1.529) has been discovered in South Africa and Botswana. Rapid identification of this variant is essential for pandemic assessment and containment. However, variant identification is mainly being performed using expensive and time-consuming genomic sequencing. In this study we propose an alternative RT-qPCR approach for the detection of the Omicron BA.1 variant using a low-cost and rapid SYBR Green method. We have designed specific primers to confirm the deletion mutations in the spike (S Δ143-145) and the nucleocapsid (N Δ31-33) which are characteristics of this variant. For the evaluation, we used 120 clinical samples from patients with PCR-confirmed SARS-CoV-2 infections, and displaying an S-gene target failure (SGTF) when using TaqPath COVID-19 kit (Thermo Fisher Scientific, Waltham, USA) that included the ORF1ab, S, and N gene targets. Our results showed that all the 120 samples harbored S Δ143-145 and N Δ31-33, which was further confirmed by Whole genome sequencing (WGS) of ten samples thereby validating our SYBR Green-based protocol. This protocol can be easily implemented to rapidly confirm the diagnosis of the Omicron BA.1 variant in COVID-19 patients and prevent its spread among populations, especially in countries with high prevalence of SGTF profile.","PeriodicalId":36528,"journal":{"name":"Biology Methods and Protocols","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biology Methods and Protocols","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/biomethods/bpae020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

The COVID-19 pandemic is unceasingly spreading across the globe, and recently a highly transmissible Omicron SARS-CoV-2 variant (B.1.1.529) has been discovered in South Africa and Botswana. Rapid identification of this variant is essential for pandemic assessment and containment. However, variant identification is mainly being performed using expensive and time-consuming genomic sequencing. In this study we propose an alternative RT-qPCR approach for the detection of the Omicron BA.1 variant using a low-cost and rapid SYBR Green method. We have designed specific primers to confirm the deletion mutations in the spike (S Δ143-145) and the nucleocapsid (N Δ31-33) which are characteristics of this variant. For the evaluation, we used 120 clinical samples from patients with PCR-confirmed SARS-CoV-2 infections, and displaying an S-gene target failure (SGTF) when using TaqPath COVID-19 kit (Thermo Fisher Scientific, Waltham, USA) that included the ORF1ab, S, and N gene targets. Our results showed that all the 120 samples harbored S Δ143-145 and N Δ31-33, which was further confirmed by Whole genome sequencing (WGS) of ten samples thereby validating our SYBR Green-based protocol. This protocol can be easily implemented to rapidly confirm the diagnosis of the Omicron BA.1 variant in COVID-19 patients and prevent its spread among populations, especially in countries with high prevalence of SGTF profile.
利用基于 SYBR 绿的 RT-qPCR 检测 SARS-CoV-2 B.1.1.529 (omicron) 变异体
COVID-19 大流行正在全球不断蔓延,最近又在南非和博茨瓦纳发现了一种传播性极强的 Omicron SARS-CoV-2 变体(B.1.1.529)。快速鉴定这种变异体对于评估和遏制大流行至关重要。然而,变异体的鉴定主要使用昂贵且耗时的基因组测序技术。在本研究中,我们提出了另一种 RT-qPCR 方法,即使用低成本、快速的 SYBR Green 方法检测 Omicron BA.1 变异体。我们设计了特异性引物来确认作为该变异体特征的尖峰(S Δ143-145)和核壳(N Δ31-33)的缺失突变。为了进行评估,我们使用了 120 份经 PCR 鉴定为 SARS-CoV-2 感染者的临床样本,并在使用包括 ORF1ab、S 和 N 基因靶标的 TaqPath COVID-19 试剂盒(Thermo Fisher Scientific, Waltham, USA)时发现 S 基因靶标失败(SGTF)。我们的结果表明,所有 120 个样本都含有 S Δ143-145 和 N Δ31-33,其中 10 个样本的全基因组测序(WGS)进一步证实了这一点,从而验证了我们基于 SYBR Green 的方案。该方案易于实施,可快速确诊 COVID-19 患者中的 Omicron BA.1 变体,并防止其在人群中传播,尤其是在 SGTF 高发国家。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biology Methods and Protocols
Biology Methods and Protocols Agricultural and Biological Sciences-Agricultural and Biological Sciences (all)
CiteScore
3.80
自引率
2.80%
发文量
28
审稿时长
19 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信